Publication | Closed Access

ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy

MedicinePathologyCancer GenomicsErcc1 ExpressionCancer TreatmentPlatinum ChemotherapyOncologyCell BiologyLung CancerTumor BiologyNovel Detection Platform